Effaclar Spotscan, which will be available on Alibaba’s Tmall and Taobao e-commerce apps in June prior to worldwide release, targets consumers suffering from skin problems with limited access to dermatologists.
“L’Oréal Group has a vision of transforming into the champion of beauty-tech companies. And China, as the important digitalisation and innovation hub for L’Oréal Group, is the most powerful driving force. Today, Effaclar Spotscan is a milestone for us to create a disruptive beauty experience with open innovation, and bring a better life for people around the world,” said L’Oréal China CEO Stéphane Rinderknech.
L’Oréal-owned skincare brand La Roche-Posay and Alibaba’s advance technologies were used in the research to help identify different types of acne.
Taobao and Tmall users can upload three selfies on the app which will give them the results on the severity of their acne and release personalised skincare tips. Afterwards, it will suggest the right products they can use and buy online. It also allows consumers to have access to a skincare expert for one-on-one consultation.
“Millions of consumers on Alibaba’s Tmall and Taobao are plagued by acne. Through AI technology, they can now gain a better understanding of the state of their skin and choose the skincare solutions that are right for them, in an effective and convenient manner, without even having to leave their homes,” Alibaba Cloud EMEA general manager Wang Yeming said.
Globally, acne issues affects 85 per cent of young adults in the 12-25 age group, according to a Global Burden of Disease study published in 2013.
“We are delighted to team up with Alibaba to bring dermatological expertise to millions of people in China with the launch of La Roche-Posay Effaclar Spotscan. This launch perfectly illustrates our vision of beauty, diversified and accessible to all, tailored to the needs and aspirations around the world and powered by digital,” Lubomira Rochet, chief digital officer of L’Oréal said.